These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18586144)

  • 21. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facial hyperhidrosis: best practice recommendations and special considerations.
    Glaser DA; Hebert AA; Pariser DM; Solish N
    Cutis; 2007 May; 79(5 Suppl):29-32. PubMed ID: 17596098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
    Wollina U; Karamfilov T; Konrad H
    J Am Acad Dermatol; 2002 Apr; 46(4):536-40. PubMed ID: 11907503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, severity, and impact of hyperhidrosis in people with lower-limb amputation.
    Hansen C; Godfrey B; Wixom J; McFadden M
    J Rehabil Res Dev; 2015; 52(1):31-40. PubMed ID: 26230919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does targeted nerve implantation reduce neuroma pain in amputees?
    Pet MA; Ko JH; Friedly JL; Mourad PD; Smith DG
    Clin Orthop Relat Res; 2014 Oct; 472(10):2991-3001. PubMed ID: 24723142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of Injection Site Pain in the Treatment of Axillary Hyperhidrosis With Botulinum Toxin: A Randomized, Side-by-Side, Comparative Study of Two Injection Patterns.
    Awaida CJ; Rayess YA; Jabbour SF; Abouzeid SM; Nasr MW
    Dermatol Surg; 2021 Jan; 47(1):154-157. PubMed ID: 31592920
    [No Abstract]   [Full Text] [Related]  

  • 27. Does a torsion adapter improve functional mobility, pain, and fatigue in patients with transtibial amputation?
    Segal AD; Kracht R; Klute GK
    Clin Orthop Relat Res; 2014 Oct; 472(10):3085-92. PubMed ID: 24733445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Common Are Chronic Residual Limb Pain, Phantom Pain, and Back Pain More Than 20 Years After Lower Limb Amputation for Malignant Tumors?
    Döring K; Trost C; Hofer C; Salzer M; Kelaridis T; Windhager R; Hobusch GM
    Clin Orthop Relat Res; 2021 Sep; 479(9):2036-2044. PubMed ID: 33739309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hyperhidrosis with botulinum toxin.
    Doft MA; Hardy KL; Ascherman JA
    Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A treatment for hyperhidrosis in patients with prosthetic limbs.
    Gratrix M; Hivnor C
    Arch Dermatol; 2010 Nov; 146(11):1314-5. PubMed ID: 21079082
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of botulinum toxin type B on stump pain and involuntary movements of the stump.
    Kern U; Martin C; Scheicher S; Müller H
    Am J Phys Med Rehabil; 2004 May; 83(5):396-9. PubMed ID: 15100632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hyperhidrosis with botulinum toxin.
    Glogau RG
    Dermatol Clin; 2004 Apr; 22(2):177-85, vii. PubMed ID: 15222578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodine-Starch test for assessment of hyperhidrosis in amputees, evaluation of different methods of application.
    Hansen C; Wayment B; Klein S; Godfrey B
    Disabil Rehabil; 2018 Dec; 40(25):3076-3080. PubMed ID: 28826272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin A dissolving microneedles for hyperhidrosis treatment: design, formulation and
    Malek-Khatabi A; Rad-Malekshahi M; Shafiei M; Sharifi F; Motasadizadeh H; Ebrahiminejad V; Rad-Malekshahi M; Akbarijavar H; Faraji Rad Z
    Biomater Sci; 2023 Dec; 11(24):7784-7804. PubMed ID: 37905676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin A for focal hyperhidrosis in leg amputees: a case report.
    Wollina U; Konrad H; Graefe T; Thiele J
    Acta Derm Venereol; 2000 May; 80(3):226-7. PubMed ID: 10954228
    [No Abstract]   [Full Text] [Related]  

  • 37. Botulinum toxin for focal hyperhidrosis of the face.
    George SM; Atkinson LR; Farrant PB; Shergill BS
    Br J Dermatol; 2014 Jan; 170(1):211-3. PubMed ID: 23909999
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of prosthesis-related residual limb wounds after botulinum toxin for secondary hyperhidrosis.
    Mountan S; Duncan C; Hansen C
    PM R; 2022 Aug; 14(8):1026-1028. PubMed ID: 34564952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.